239610 — HL Science Co Balance Sheet
0.000.00%
- KR₩63bn
- KR₩37bn
- KR₩18bn
- 44
- 27
- 12
- 14
Annual balance sheet for HL Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 65,864 | 57,535 | 29,338 | 28,616 | 26,868 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,303 | 5,808 | 1,652 | 2,797 | 1,894 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 78,789 | 71,276 | 37,236 | 38,865 | 33,187 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 17,334 | 35,576 | 44,974 | 43,993 | 42,855 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 107,059 | 117,865 | 108,818 | 105,969 | 97,778 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,140 | 9,515 | 3,842 | 3,244 | 1,990 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 11,220 | 10,607 | 4,602 | 3,548 | 3,234 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 95,840 | 107,258 | 104,215 | 102,421 | 94,544 |
Total Liabilities & Shareholders' Equity | 107,059 | 117,865 | 108,818 | 105,969 | 97,778 |
Total Common Shares Outstanding |